Related Experiment Video

Updated: Mar 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Targeting ALK: The Ten Lives of a Tumor

Rogier Versteeg1, Rani E George2

  • 1Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. r.versteeg@amc.nl Rani_George@DFCI.Harvard.edu.

Cancer Discovery
|January 10, 2016
PubMed

Insights

A novel ALK/ROS1 inhibitor, PF-06463922, shows promise in preclinical neuroblastoma models. While effective against mutated ALK, further research is needed before it can be considered a definitive treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Neuroblastoma is a pediatric cancer often driven by mutations in ALK or ROS1.
  • Targeted therapies are crucial for improving outcomes in neuroblastoma patients.

Discussion:

  • PF-06463922 demonstrates potent inhibition of ALK/ROS1 signaling in preclinical neuroblastoma models.
  • The drug effectively suppressed tumor growth in patient-derived xenografts with mutated ALK.

Key Insights:

  • Preclinical data suggest PF-06463922 is a promising candidate for neuroblastoma treatment.
  • The inhibitor's efficacy in models with mutated ALK highlights its targeted potential.

Outlook:

  • Further investigation and clinical trials are warranted to evaluate PF-06463922's safety and efficacy in humans.
  • While promising, PF-06463922 is not yet a "magic bullet" and requires comprehensive evaluation.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K